BioLineRx (BLRX)
(Delayed Data from NSDQ)
$0.64 USD
-0.02 (-3.05%)
Updated Sep 23, 2024 03:58 PM ET
After-Market: $0.64 0.00 (-0.44%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBioLineRx Ltd. (BLRX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$13.75 | $21.00 | $6.50 | 1,983.33% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for BioLineRx Ltd. comes to $13.75. The forecasts range from a low of $6.50 to a high of $21.00. The average price target represents an increase of 1% from the last closing price of $0.66.
Analyst Price Targets (2 )
Broker Rating
Only one brokerage firm provided a Strong Buy-equivalent recommendation for BioLineRx Ltd. This translates to an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell). ABR is the calculated average of actual recommendations (Buy, Hold, Sell etc.) made by brokerage firms.
The current ABR compares to an ABR of 1.00 a month ago based on just one Strong Buy recommendation.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/3/2024 | H.C. Wainwright & Co. | Joseph Pantginis | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 1 |
Average Target Price | $13.75 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 89 of 253 |
Current Quarter EPS Est: | -0.09 |
BLRX FAQs
BioLineRx Ltd. (BLRX) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 1 brokerage firms.
The average price target for BioLineRx Ltd. (BLRX) is $13.75. The current on short-term price targets is based on 2 reports.
The forecasts for BioLineRx Ltd. (BLRX) range from a low of $6.5 to a high of $21. The average price target represents a increase of $2048.44 from the last closing price of $.64.
The current UPSIDE for BioLineRx Ltd. (BLRX) is 2048.44%
Based on short-term price targets offered by two analysts, the average price target for BioLineRx Ltd. comes to $13.75. The forecasts range from a low of $6.50 to a high of $21.00. The average price target represents an increase of 1% from the last closing price of $0.66.